Modal Container (Shows only in EE)
Modal ID: #cookie-management-modal
Open Modal
Close Modal

-

REPORT

Milliman Study on the Utility of ICER Reports for Private Payer Drug Coverage Decision-Making

To download the full report, click here.

A new whitepaper authored by Bruce Pyenson, F.S.A., M.A.A.A. and colleagues from Milliman explains why Institute for Clinical and Economic Review (ICER) cost-effective analyses (CEAs) will not be very useful for private payers’ medicine coverage decisions. The whitepaper identifies several problems in applying ICER’s reports to inform coverage decisions by private payers

DOWNLOAD FULL REPORT

-

DOWNLOAD THE ONE-PAGER

-

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.